IMNM
Immunome·NASDAQ
--
--(--)
--
--(--)
IMNM fundamentals
Immunome (IMNM) released its earnings on Aug 6, 2025: revenue was 4.01M (YoY +69.84%), beat estimates; EPS was -0.5 (YoY +16.67%), beat estimates.
Revenue / YoY
4.01M
+69.84%
EPS / YoY
-0.5
+16.67%
Report date
Aug 6, 2025
Earnings Call
9:30 AM on Aug 6, 2025
Meeting link.EPS
Actual | -0.4 | -0.37 | -0.46 | -0.65 | -0.65 | -0.96 | -0.74 | -0.75 | -0.64 | -0.35 | -0.46 | -0.36 | -4.21 | -2.51 | -0.6 | -0.78 | -1.11 | -0.52 | -0.5 |
Forecast | -0.29 | -0.41 | -0.39 | -0.505 | -0.81 | -0.69 | -0.93 | -0.76 | -0.675 | 0.585 | -0.16 | -0.17 | -0.2733 | -0.68 | -0.3794 | -0.5514 | -0.6408 | -0.6348 | -0.5167 |
Surprise | -37.93% | +9.76% | -17.95% | -28.71% | +19.75% | -39.13% | +20.43% | +1.32% | +5.19% | -159.83% | -187.50% | -111.76% | -1440.43% | -269.12% | -58.14% | -41.46% | -73.22% | +18.08% | +3.23% |
Revenue
Actual | -- | -- | 0 | 0 | 0 | -- | -- | 0 | -- | 2.36M | 4.26M | 3.56M | 3.84M | 1.03M | 2.36M | 2.91M | 2.74M | 2.93M | 4.01M |
Forecast | 2.10M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.07M | 2.80M | 1.87M | 2.29M | 3.15M | 783.26K | 833.33K |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +85.71% | -63.25% | +26.64% | +27.12% | -12.90% | +273.56% | +381.80% |
Earnings Call
You can ask Aime
What guidance did Immunome's management provide for the next earnings period?What were the key takeaways from Immunome's earnings call?What were the key takeaways from Immunome’s earnings call?What factors drove the changes in Immunome's revenue and profit?What is the market's earnings forecast for Immunome next quarter?What is the revenue and EPS growth rate for Immunome year over year?What is Immunome's latest dividend and current dividend yield?What does Immunome do and what are its main business segments?
